BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35862373)

  • 21. Hypoxia differentially regulates VEGFR1 and VEGFR2 levels and alters intracellular signaling and cell migration in endothelial cells.
    Ulyatt C; Walker J; Ponnambalam S
    Biochem Biophys Res Commun; 2011 Jan; 404(3):774-9. PubMed ID: 21168388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dimerization of VEGF receptors and implications for signal transduction: a computational study.
    Mac Gabhann F; Popel AS
    Biophys Chem; 2007 Jul; 128(2-3):125-39. PubMed ID: 17442480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting signaling pathways of VEGFR1 and VEGFR2 as a potential target in the treatment of breast cancer.
    Farzaneh Behelgardi M; Zahri S; Gholami Shahvir Z; Mashayekhi F; Mirzanejad L; Asghari SM
    Mol Biol Rep; 2020 Mar; 47(3):2061-2071. PubMed ID: 32072404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential roles of vascular endothelial growth factor receptors 1 and 2 in dendritic cell differentiation.
    Dikov MM; Ohm JE; Ray N; Tchekneva EE; Burlison J; Moghanaki D; Nadaf S; Carbone DP
    J Immunol; 2005 Jan; 174(1):215-22. PubMed ID: 15611243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. VEGF165b Modulates Endothelial VEGFR1-STAT3 Signaling Pathway and Angiogenesis in Human and Experimental Peripheral Arterial Disease.
    Ganta VC; Choi M; Kutateladze A; Annex BH
    Circ Res; 2017 Jan; 120(2):282-295. PubMed ID: 27974423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of VEGF and its receptors VEGFR1/VEGFR2 is associated with invasiveness of bladder cancer.
    Kopparapu PK; Boorjian SA; Robinson BD; Downes M; Gudas LJ; Mongan NP; Persson JL
    Anticancer Res; 2013 Jun; 33(6):2381-90. PubMed ID: 23749886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Receptor-Mediated Endocytosis of VEGF-A in Rat Liver Sinusoidal Endothelial Cells.
    Mousavi SA; Skjeldal F; Fønhus MS; Haugen LH; Eskild W; Berg T; Bakke O
    Biomed Res Int; 2019; 2019():5496197. PubMed ID: 31583245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Herbal compound farnesiferol C exerts antiangiogenic and antitumor activity and targets multiple aspects of VEGFR1 (Flt1) or VEGFR2 (Flk1) signaling cascades.
    Lee JH; Choi S; Lee Y; Lee HJ; Kim KH; Ahn KS; Bae H; Lee HJ; Lee EO; Ahn KS; Ryu SY; Lü J; Kim SH
    Mol Cancer Ther; 2010 Feb; 9(2):389-99. PubMed ID: 20103598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. r84, a novel therapeutic antibody against mouse and human VEGF with potent anti-tumor activity and limited toxicity induction.
    Sullivan LA; Carbon JG; Roland CL; Toombs JE; Nyquist-Andersen M; Kavlie A; Schlunegger K; Richardson JA; Brekken RA
    PLoS One; 2010 Aug; 5(8):e12031. PubMed ID: 20700512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A peptide mimicking the binding sites of VEGF-A and VEGF-B inhibits VEGFR-1/-2 driven angiogenesis, tumor growth and metastasis.
    Farzaneh Behelgardi M; Zahri S; Mashayekhi F; Mansouri K; Asghari SM
    Sci Rep; 2018 Dec; 8(1):17924. PubMed ID: 30560942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascularization via activation of VEGF-VEGFR signaling is essential for peripheral nerve regeneration.
    Nishida Y; Yamada Y; Kanemaru H; Ohazama A; Maeda T; Seo K
    Biomed Res; 2018; 39(6):287-294. PubMed ID: 30531158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and localization of vascular endothelial growth factor and its receptors in the pig uterus during peri-implantation and determination of the in vitro effect of the angiogenesis inhibitor SU5416 on VEGF system expression.
    González López R; Contreras Caro Del Castillo DA; Valdez Magaña G; Sarmiento Silva RE; Martínez Castañeda FE; Trujillo Ortega ME
    Theriogenology; 2023 Sep; 207():49-60. PubMed ID: 37269596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular endothelial growth factor receptor 1 expression in nasal polyp tissue.
    Bobic S; Hox V; Callebaut I; Vinckier S; Jonckx B; Stassen JM; Jorissen M; Gevaert P; Carmeliet P; Bachert C; Ceuppens JL; Hellings PW
    Allergy; 2014 Feb; 69(2):237-45. PubMed ID: 24127643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of VEGF-R1 and VEGF-R2 ligands on angiogenic responses and left ventricular function in mice.
    Huusko J; Merentie M; Dijkstra MH; Ryhänen MM; Karvinen H; Rissanen TT; Vanwildemeersch M; Hedman M; Lipponen J; Heinonen SE; Eriksson U; Shibuya M; Ylä-Herttuala S
    Cardiovasc Res; 2010 Apr; 86(1):122-30. PubMed ID: 19955220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer.
    Carrillo de Santa Pau E; Arias FC; Caso Peláez E; Muñoz Molina GM; Sánchez Hernández I; Muguruza Trueba I; Moreno Balsalobre R; Sacristán López S; Gómez Pinillos A; del Val Toledo Lobo M
    Cancer; 2009 Apr; 115(8):1701-12. PubMed ID: 19197998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential expression of vascular endothelial growth factor implies the limbal origin of pterygia.
    Gebhardt M; Mentlein R; Schaudig U; Pufe T; Recker K; Nölle B; Al-Samir K; Geerling G; Paulsen FP
    Ophthalmology; 2005 Jun; 112(6):1023-30. PubMed ID: 15885787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VEGF164(165) as the pathological isoform: differential leukocyte and endothelial responses through VEGFR1 and VEGFR2.
    Usui T; Ishida S; Yamashiro K; Kaji Y; Poulaki V; Moore J; Moore T; Amano S; Horikawa Y; Dartt D; Golding M; Shima DT; Adamis AP
    Invest Ophthalmol Vis Sci; 2004 Feb; 45(2):368-74. PubMed ID: 14744874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DDA suppresses angiogenesis and tumor growth of colorectal cancer in vivo through decreasing VEGFR2 signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Oncotarget; 2016 Sep; 7(39):63124-63137. PubMed ID: 27517319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production of VEGF receptor 1 and 2 mRNA and protein during endochondral bone repair is differential and healing phase specific.
    Reumann MK; Nair T; Strachna O; Boskey AL; Mayer-Kuckuk P
    J Appl Physiol (1985); 2010 Dec; 109(6):1930-8. PubMed ID: 20947709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A biphasic endothelial stress-survival mechanism regulates the cellular response to vascular endothelial growth factor A.
    Latham AM; Odell AF; Mughal NA; Issitt T; Ulyatt C; Walker JH; Homer-Vanniasinkam S; Ponnambalam S
    Exp Cell Res; 2012 Nov; 318(18):2297-311. PubMed ID: 22796052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.